11 November 2021

Radboud university medical center, Radboud University and 13 other organisations involved in animal testing in the Netherlands have signed the Dutch Transparency Agreement on Animal Testing. The institutes commit themselves to communicate in a more open way about how animals are used in research.

The group of signatories consists of universities, university medical centres, scientific institutes, companies, and associations.

The signatories are: Amsterdam UMC, Biomedical Primate Research Centre, Charles River Laboratories Den Bosch B.V., Envigo RMS B.V., Erasmus University Medical Center, Leiden University, Maastricht University, Netherlands Cancer Institute, Radboudumc, Radboud University, Royal Netherlands Academy of Arts and Sciences, University of Groningen, Vereniging Sportvisserij Nederland, Vrije Universiteit Amsterdam, Wageningen University & Research.

Transparency

The importance of good and transparent communication about animal research is becoming increasingly recognised. This agreement was drafted by various Dutch researchers in collaboration with the European Animal Research Association (EARA) and Stichting Informatie Dierproeven (SID) and is inspired by existing transparency agreements from Belgium, France, Germany, Portugal, Spain and the United Kingdom.

The aim is to create a more open and transparent climate around animal research, a subject that usually leads to heated discussions in society, the media and politics. As animal testing is such a sensitive topic, it is essential to provide context to communicate the benefits of using animal models. Dutch research institutes already share a lot of information and data about their animal research, but that information is not always easily accessible for the public. The signatories hope that this transparency agreement will make a positive contribution towards creating more openness and informed discussion about animal testing.

Four commitments

The signatories are involved in carrying out, supporting or funding animal experiments for the benefit of human and animal health, quality of life and nature and the environment. By signing, the organisations make the following four commitments:

  1. We are clear about when, how and why we use animals in research.
  2. We will enhance our communication with the media and the public about our involvement in animal research in the Netherlands.
  3. We will be proactive in providing opportunities for the public to inform themselves about research using animals and the regulations that govern it.
  4. We will report on our progress annually and share our experiences.

“This is a big step forward for the biomedical sector in the Netherlands,” said EARA executive director Kirk Leech. “It has been shown that transparency agreements in other European countries have led to a much more informed and evidence-based debate in society on the use of animals in research.”

Monique Havermans, neuroscientist and EARA’s representative: “The debate in the Netherlands is fierce, even though most people seem to have the same opinion on the topic; replace animal experiments wherever possible. We need context, accurate information from those performing animal experiments and acknowledgement from those whose work and accomplishments has been built on animal research.”

Wilbert Frieling, chair of SID adds: “With the kick-off of the Transparency Agreement, we hope to see more parties join the initiative in the future, making it easier to talk about animal research in the Netherlands.”

Judith Homberg, professor, concludes: “Collaboration between universities and companies on high-tech methods can lead to the refinement and reduction in animal testing, as we will pitch today at the Holland High-Tech meeting. The transparency agreement offers us opportunities to inform the public on such new developments”.

The summary of the agreement can be downloaded here (link to external webpage).

Related news items


Vote for the Supervisor of the year

7 December 2021

Now you have the chance to vote for your preferred candidate. Have fun, and go for it, support and promote your ideal supervisor. Please submit your vote at the latest 20 December 2021.

read more

How much should we exercise to live healthier lives? Research into the relationship between exercise, heart disease and mortality

3 December 2021

It has long been known that exercise reduces the risk of many chronic diseases. However, we do not yet know exactly how much exercise is necessary to achieve health benefit.

read more

KNAW Early Career Award for Martine Hoogman

2 December 2021

Martine Hoogman has been awarded a KNAW Early Career Award. The prize, a sum of 15,000 euros and a work of art, is aimed at researchers in the Netherlands who are at the start of their careers and have innovative, original research ideas.

read more

T-Guard can reset immune system

1 December 2021

For 20 years, the Nijmegen based Radboudumc spin-off company Xenikos has been working on a drug that can reset the immune system. This reset will save lives of seriously ill patients. Now, after years of hard work, the moment of truth has arrived for T-guard.

read more

Thomas van den Heuvel wins Stairway to Impact Award for safer pregnancies using AI Award for safer pregnancies using AI

1 December 2021

Radboudumc researcher Thomas van den Heuvel receives the Stairway to Impact Award from Dutch Research Council NWO. He receives this prize for the development of the BabyChecker, a smartphone application that allows midwives to make ultrasounds during pregnancies.

read more

Villa Joep Research Grant for Radiotherapy & OncoImmunology (ROI) lab

1 December 2021

Renske van den Bijgaart and Gosse Adema from the Radiotherapy & OncoImmunology laboratorium in collaboration with the Prinses Maxima Center received a grant from Villa Joep of 410k Euro.

read more